Ivan D. Horak
2007
In 2007, Ivan D. Horak earned a total compensation of $1.8M as Executive Vice President Research and Development and Chief Scientific Officer at Enzon Pharmaceuticals, a 41% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $350,000 |
|---|---|
| Option Awards | $688,998 |
| Salary | $498,293 |
| Stock Awards | $256,589 |
| Other | $26,235 |
| Total | $1,820,115 |
Horak received $689K in option awards, accounting for 38% of the total pay in 2007.
Horak also received $350K in non-equity incentive plan, $498.3K in salary, $256.6K in stock awards and $26.2K in other compensation.
Rankings
In 2007, Ivan D. Horak's compensation ranked 2,539th out of 8,700 executives tracked by ExecPay. In other words, Horak earned more than 70.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,539 out of 8,700 | 71st |
Division Manufacturing | 866 out of 3,314 | 74th |
Major group Chemicals And Allied Products | 163 out of 746 | 78th |
Industry group Drugs | 87 out of 546 | 84th |
Industry Biological Products, Except Diagnostic Substances | 18 out of 118 | 85th |
Source: SEC filing on April 16, 2008.
Horak's colleagues
We found four more compensation records of executives who worked with Ivan D. Horak at Enzon Pharmaceuticals in 2007.
2007
Jeffrey Buchalter
Enzon Pharmaceuticals
Chief Executive Officer
2007
Craig Tooman
Enzon Pharmaceuticals
Chief Financial Officer
2007
Ralph del Campo
Enzon Pharmaceuticals
Executive Vice President, Technical Operations
2007
Paul Davit
Enzon Pharmaceuticals